Skip to main content

Is meta-analysis the optimal method to decide the duration of antiplatelet therapy in diabetic patients treated with drug‑eluting stenting?

Publication ,  Journal Article
Tantry, US; Gurbel, PA
Published in: Pol Arch Intern Med
September 30, 2021

Duke Scholars

Published In

Pol Arch Intern Med

DOI

EISSN

1897-9483

Publication Date

September 30, 2021

Volume

131

Issue

9

Start / End Page

776 / 778

Location

Poland

Related Subject Headings

  • Treatment Outcome
  • Stents
  • Platelet Aggregation Inhibitors
  • Pharmaceutical Preparations
  • Humans
  • Diabetes Mellitus
  • Cardiovascular System & Hematology
  • Aspirin
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tantry, U. S., & Gurbel, P. A. (2021). Is meta-analysis the optimal method to decide the duration of antiplatelet therapy in diabetic patients treated with drug‑eluting stenting? Pol Arch Intern Med, 131(9), 776–778. https://doi.org/10.20452/pamw.16080
Tantry, Udaya S., and Paul A. Gurbel. “Is meta-analysis the optimal method to decide the duration of antiplatelet therapy in diabetic patients treated with drug‑eluting stenting?Pol Arch Intern Med 131, no. 9 (September 30, 2021): 776–78. https://doi.org/10.20452/pamw.16080.
Tantry, Udaya S., and Paul A. Gurbel. “Is meta-analysis the optimal method to decide the duration of antiplatelet therapy in diabetic patients treated with drug‑eluting stenting?Pol Arch Intern Med, vol. 131, no. 9, Sept. 2021, pp. 776–78. Pubmed, doi:10.20452/pamw.16080.

Published In

Pol Arch Intern Med

DOI

EISSN

1897-9483

Publication Date

September 30, 2021

Volume

131

Issue

9

Start / End Page

776 / 778

Location

Poland

Related Subject Headings

  • Treatment Outcome
  • Stents
  • Platelet Aggregation Inhibitors
  • Pharmaceutical Preparations
  • Humans
  • Diabetes Mellitus
  • Cardiovascular System & Hematology
  • Aspirin
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology